Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant
Clinical trial NCT05046613 · RECRUITING
Trial details
- NCT number
- NCT05046613
- Sponsor
- Pfizer
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2021-09-23
- Primary completion
- 2029-11-04
- Enrollment
- 780
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.